These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 8894118
1. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats. Yamazaki M, Kobayashi K, Sugiyama Y. Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118 [Abstract] [Full Text] [Related]
2. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats. Yamazaki M, Kobayashi K, Sugiyama Y. Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045 [Abstract] [Full Text] [Related]
3. Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. Yamazaki M, Akiyama S, Ni'inuma K, Nishigaki R, Sugiyama Y. Drug Metab Dispos; 1997 Oct; 25(10):1123-9. PubMed ID: 9321514 [Abstract] [Full Text] [Related]
4. Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide. Yamada T, Niinuma K, Lemaire M, Terasaki T, Sugiyama Y. J Pharmacol Exp Ther; 1996 Dec; 279(3):1357-64. PubMed ID: 8968360 [Abstract] [Full Text] [Related]
5. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR). Ishizuka H, Konno K, Naganuma H, Sasahara K, Kawahara Y, Niinuma K, Suzuki H, Sugiyama Y. J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317 [Abstract] [Full Text] [Related]
6. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. Sasabe H, Tsuji A, Sugiyama Y. J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864 [Abstract] [Full Text] [Related]
7. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat. Sasabe H, Kato Y, Tsuji A, Sugiyama Y. J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812 [Abstract] [Full Text] [Related]
8. Alterations in glutathione homeostasis in mutant Eisai hyperbilirubinemic rats. Lu SC, Cai J, Kuhlenkamp J, Sun WM, Takikawa H, Takenaka O, Horie T, Yi J, Kaplowitz N. Hepatology; 1996 Jul; 24(1):253-8. PubMed ID: 8707271 [Abstract] [Full Text] [Related]
9. Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan. Nishino A, Kato Y, Igarashi T, Sugiyama Y. Drug Metab Dispos; 2000 Oct; 28(10):1146-8. PubMed ID: 10997931 [Abstract] [Full Text] [Related]
10. Alterations in the pharmacokinetics and protein binding of enprofylline in Eisai hyperbilirubinemic rats. Nadai M, Hasegawa T, Wang L, Tagaya O, Nabeshima T. Drug Metab Dispos; 1994 Oct; 22(4):561-5. PubMed ID: 7956730 [Abstract] [Full Text] [Related]
11. Biliary excretion of copper, manganese, and horseradish peroxidase in Eisai hyperbilirubinemic mutant rats (EHBRs) with defective biliary excretion of glutathione. Sugawara N, Lai Y, Yuasa M, Dhar SK, Arizono K. Biol Trace Elem Res; 1996 Oct; 55(1-2):181-9. PubMed ID: 8971365 [Abstract] [Full Text] [Related]
12. Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system. Yamazaki M, Tokui T, Ishigami M, Sugiyama Y. Biopharm Drug Dispos; 1996 Dec; 17(9):775-89. PubMed ID: 8968530 [Abstract] [Full Text] [Related]
13. Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. Sathirakul K, Suzuki H, Yasuda K, Hanano M, Tagaya O, Horie T, Sugiyama Y. J Pharmacol Exp Ther; 1993 Jun; 265(3):1301-12. PubMed ID: 8510010 [Abstract] [Full Text] [Related]
14. Nonlinear disposition kinetics of a novel antifolate, MX-68, in rats. Han YH, Kato Y, Sugiyama Y. J Pharmacol Exp Ther; 1999 Oct; 291(1):204-12. PubMed ID: 10490906 [Abstract] [Full Text] [Related]
15. Species differences in the transport activity for organic anions across the bile canalicular membrane. Ishizuka H, Konno K, Shiina T, Naganuma H, Nishimura K, Ito K, Suzuki H, Sugiyama Y. J Pharmacol Exp Ther; 1999 Sep; 290(3):1324-30. PubMed ID: 10454510 [Abstract] [Full Text] [Related]
16. Carrier-mediated hepatic uptake of the cationic cyclopeptide, octreotide, in rats. Comparison between in vivo and in vitro. Yamada T, Niinuma K, Lemaire M, Terasaki T, Sugiyama Y. Drug Metab Dispos; 1997 May; 25(5):536-43. PubMed ID: 9152591 [Abstract] [Full Text] [Related]
18. Hepatic uptake of bromosulfophthalein-glutathione in perfused Eisai hyperbilirubinemic mutant rat liver: a multiple-indicator dilution study. Geng W, Schwab AJ, Horie T, Goresky CA, Pang KS. J Pharmacol Exp Ther; 1998 Feb; 284(2):480-92. PubMed ID: 9454788 [Abstract] [Full Text] [Related]
19. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Masuda M, I'izuka Y, Yamazaki M, Nishigaki R, Kato Y, Ni'inuma K, Suzuki H, Sugiyama Y. Cancer Res; 1997 Aug 15; 57(16):3506-10. PubMed ID: 9270020 [Abstract] [Full Text] [Related]
20. Mechanism of hepatobiliary transport of a novel thromboxane A2 receptor antagonist, [2-(4-chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335), and its xenobiotic taurine conjugate (Z-335-Tau) in rats. Kawabata Y, Nakamura H, Kamada E, Furuta S, Shinozaki Y, Kurimoto T, Nishigaki R. J Pharm Sci; 2003 Jan 15; 92(1):67-76. PubMed ID: 12486683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]